Results 21 to 30 of about 4,501 (176)

Racial Differences in Atrial Cardiopathy Phenotypes in Patients With Ischemic Stroke. [PDF]

Neurology, 2021
To test the hypothesis that thrombogenic atrial cardiopathy may be relevant to stroke-related racial disparities, we compared atrial cardiopathy phenotypes between Black vs White patients with ischemic stroke.We assessed markers of atrial cardiopathy in the Greater Cincinnati/Northern Kentucky Stroke Study, a study of stroke incidence in a population ...
Kamel H, Alwell K, Kissela BM, Sucharew HJ, Woo D, Flaherty M, Ferioli S, Demel SL, Moomaw CJ, Walsh K, Mackey J, De Los Rios La Rosa F, Jasne A, Slavin S, Martini S, Adeoye O, Baig T, Chen ML, Levitan EB, Soliman EZ, Kleindorfer DO.   +20 more
europepmc   +4 more sources

Atrial Cardiopathy: A Broadened Concept of Left Atrial Thromboembolism Beyond Atrial Fibrillation [PDF]

Future Cardiology, 2015
Atrial fibrillation (AF) has long been associated with a heightened risk of ischemic stroke and systemic thromboembolism, but recent data require a re-evaluation of our understanding of the nature of this relationship. New findings about the temporal connection between AF and stroke, alongside evidence linking markers of left atrial abnormalities with ...
Hooman, Kamel, Peter M, Okin, W T, Longstreth, Mitchell S V, Elkind, Elsayed Z, Soliman   +4 more
openaire   +4 more sources

Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA‐Cognition Study [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background ARCADIA (Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke), a secondary stroke prevention study comparing apixaban versus aspirin for cryptogenic stroke and biomarkers of atrial cardiopathy, ended prematurely ...
Ronald M. Lazar, George Howard, Michael T. Brewer, Christy Cassarly, Qi Pauls, Stephanie Kemp, David L. Tirschwell, Kevin N. Sheth, Max Wintermark, Hooman Kamel, W. T. Longstreth Jr, Mitchell S.V. Elkind, Joseph P. Broderick, Maarten G. Lansberg   +13 more
doaj   +2 more sources

Atrial Cardiopathy Worsens Neurological Severity, Raises Recurrence Rates, and Leads to Poor Vascular Outcomes in Patients With Embolic Stroke of Undetermined Source [PDF]

Journal of Stroke
Background and Purpose Atrial cardiopathy (AC) has been studied for its significance in embolic stroke of undetermined source (ESUS). This real-world study examines the relevance of AC in ESUS and its impact on stroke severity, recurrence, and major ...
Sung Hun Kim, Hyung Jun Kim, Hyun Kyung Kim, Jang-Hyun Baek, Hahn Young Kim, Yang-Ha Hwang, Sung Hyuk Heo, Ho Geol Woo, Hyungjong Park, Sung-Il Sohn, Chi Kyung Kim, Jin-Man Jung, Sang-Hun Lee, Jae-Kwan Cha, Hee-Joon Bae, Beom Joon Kim, Bum Joon Kim, Ji Sung Lee, Hyo Suk Nam, Jee-Hyun Kwon, Wook-Ju Kim, Hee-Kwon Park, Man-Seok Park, Kang-Ho Choi, Jay Chol Choi, Joong-Goo Kim, Chul-Hoo Kang, Kwang Yeol Park, Young Seo Kim, Gyeong-Moon Kim, Oh Young Bang, Jong-Won Chung, Sung-A Chang, Tae-Jin Song, Moo-Seok Park, Min Kyoung Kang, Sun Uck Kwon, Woo-Keun Seo   +37 more
doaj   +2 more sources

Atrial Cardiopathy and Cryptogenic Stroke: A Cross-sectional Pilot Study. [PDF]

J Stroke Cerebrovasc Dis, 2016
There is increasing evidence that left atrial dysfunction or cardiopathy is associated with ischemic stroke risk independently of atrial fibrillation. We aimed to determine the prevalence of atrial cardiopathy biomarkers in patients with cryptogenic stroke.We included consecutive patients with ischemic stroke enrolled in the New York Columbia ...
Yaghi S, Boehme AK, Hazan R, Hod EA, Canaan A, Andrews HF, Kamel H, Marshall RS, Elkind MS.   +8 more
europepmc   +4 more sources

Heart Rhythm Monitoring Practices, Detection of Atrial Fibrillation, and Effect of Anticoagulation in the ARCADIA Trial [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The ARCADIA (Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke) trial found no benefit of anticoagulation for preventing recurrent stroke in patients with atrial cardiopathy.
Hooman Kamel, Mitchell S.V. Elkind, Richard A. Kronmal, Rebeca Aragon Garcia, Pamela Plummer, Joseph P. Broderick, Qi Pauls, Jordan J. Elm, Marco R. Di Tullio, Elsayed Z. Soliman, Jeff S. Healey, Shadi Yaghi, Tina M. Burton, David L. Tirschwell, W. T. Longstreth   +14 more
doaj   +2 more sources

Atrial Cardiopathy: Etiology of recurrent stroke

Indian Pacing and Electrophysiology Journal, 2022
S. Kakarla, R. Lotlikar, N. Namboodiri, S.E. Sreedharan   +3 more
doaj   +2 more sources

Embolic stroke of undetermined source: beyond atrial fibrillation

Neurología (English Edition), 2022
Introduction: Embolic stroke of undetermined source (ESUS) accounts for 25% of all cerebral infarcts; only 30% are associated with paroxysmal atrial fibrillation (AF).
A. Arauz, C. Arteaga, C. Zapata-Gómez, C. Ramos-Ventura, B. Méndez, R. Otiniano-Sifuentes, S. Haseeb, R. González-Oscoy, A. Baranchuk   +8 more
doaj   +1 more source

Infarto cerebral embólico de origen no determinado: más allá de la fibrilación auricular

Neurología, 2022
Resumen: Introducción: El infarto cerebral embólico de origen no determinado (ESUS por sus siglas en inglés) representa el 25% de todos los infartos cerebrales y solo el 30% se asocia con fibrilación auricular (FA) paroxística.
A. Arauz, C. Arteaga, C. Zapata-Gómez, C. Ramos-Ventura, B. Méndez, R. Otiniano-Sifuentes, S. Haseeb, R. González-Oscoy, A. Baranchuk   +8 more
doaj   +1 more source

Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined Source. [PDF]

Stroke, 2020
Kamel H, Pearce LA, Ntaios G, Gladstone DJ, Perera K, Roine RO, Meseguer E, Shoamanesh A, Berkowitz SD, Mundl H, Sharma M, Connolly SJ, Hart RG, Healey JS.   +13 more
europepmc   +2 more sources